- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02942459
Music Therapy Towards Schizophrenia, Negative Symptoms
Music Therapy for Treatment of Patients Suffering From Schizophrenia With Negative Symptoms - A Double-blinded Study
The Aim of this National study is to examine whether music therapy can reduce negative symptoms and raise Quality of Life for patients suffering from Schizophrenia. It is an Randomized Controlled Trial (RCT), double-blinded study with two arms. 120 Participants are anticipated. The two Arms consist of 25 weekly hours of Music Therapy by educated Music Therapists and time compensated Music Listening by unknown Care Staff Members.
The Study is a close Cooperation between Aalborg University (The Music Therapy Research Clinic) and Aalborg University Hospital, Psychiatry.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Schizophrenia includes 1 % of the Population in Denmark (DK) and often ends up to be chronically. Negative Symptoms are difficult to reduce by Medication and Psychosocial Treatment Possibilities are searched for. Three Cochrane Reviews (2005, 2011, 2017) have been conducted concerning Music Therapy and Schizophrenia with Positive Results. This RCT, double-blinded Study aims at verifying, if these Results can be Recognized in the Danish Health System. It also aims at being similar to Biomedical Study Designs as much as possible to strengthen the Evidence of the Study. A Power Calculation showed, that a minimum of 44,5 Participants in each Arm should be available, but as drop out can be anticipated with this Population, 60 Participants in each Arm were recommended. The screening Procedure is Comprehensive as it aims at securing, that the negative Symptoms are part of the Illness Schizophrenia and not side Effects from Medication or simultaneous Depression (See the Inclusion- and Exclusion criteria).
The Measurement Tools are as follows:
At Baseline, after 15 Sessions and at Termination:
- The Positive and Negative Syndrome Scale (PANSS),
- Brief Negative Symptom Scale (BNSS),
- Quality of Life (WHOQOL-Bref),
- Calgary Depression Scale for Schizophrenia (CDSS),
- Board of Clinical Examinations (Danish Questionnaire) (UKU)
- Global Assessment of Functioning Scale (GAF) 4 Weeks after Termination Follow Up Interview. In the Arm of Music Therapy Audio Recording of Music Interventions are done in Session 1,15 and 25.
- Helping Alliance Questionnaire, patient version, (Haq-II) This Haq-II is filled out after 5 sessions and after 15 Sessions and at Termination together with a Research Assistant in both Arms.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Inge N. Pedersen, PhDAss. Prof
- Phone Number: +45 26229614
- Email: innp@rn.dk
Study Contact Backup
- Name: René Ernst Nielsen, PhDAss.Prof
- Phone Number: +45 28722962
- Email: ren@rn.dk
Study Locations
-
-
North Jutland
-
Aalborg, North Jutland, Denmark, 9000
- Recruiting
- Aalborg University Hospital
-
Contact:
- Inge N. Pedersen, PhDAss. Prof
- Phone Number: +45 26229614
- Email: innp@rn.dk
-
Contact:
- René Ernst Nielsen, PhDAss. Prof
- Phone Number: +45 28722962
- Email: ren@rn.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 - 65 years
- A Diagnosis of Schizophrenia International Classification of Diseases (ICD-10 (F20))
- The Positive and Negative Syndrome Scale (PANNS), negative subscale has to show ≥ 4 on two of the following parameters:
(N1) subdued affect, (N2) emotional withdrawal, (N3) poor contact and (N4) passive/apathetic social withdrawal.
Exclusion Criteria:
- Debut of schizophrenia less than 2 years ago.
- Patients in acute worsening of schizophrenia defined as hospitalization within the last three months.
- PANNS positive subscale (P1-P7) >28.
- Patients who have their psychotropics changed within the last months.
- Significant drug dependency conflicting participation in the study.
- Presence of secondary symptoms defined as Depression - CDSS score > 7
- Neurological side effects - UKU score > 1 in one of the following items: 2.1, 2.2, 2.3, 2.5, 2.6
- Sedative side effects - UKU item 1.3 score > 1.
- No individual music therapy within the last two months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Music Therapy
25 Weekly Hours of Music Therapy adapted to the Needs of the Participants. Interventions can be Active (playing Music, singing, improvising, Song-writing) or Receptive (Listening to selected Play-lists, or to the Participants´ favored Music). A Manual is created and trained with the Music Therapists, which distinguishes between
|
25 Weekly Hours of Music Therapy by an Educated Music Therapist
|
Active Comparator: Music Listening
25 Weekly Hours of Being together with an unknown Care Staff Member listening to Music from selected Play-Lists. Music Therapists at the Music Therapy Research Clinic at Aalborg University Hospital, Psychiatry have developed Play-Lists in a Taxonomy from very Supportive to less Supportive Music including around 100 Hours of Music all together on the Lists. A Manual is created and trained with the Care Staff Members. Here the Activities are much more limited (only Music Listening to the Play-Lists are allowed). No Therapeutical Conversation is allowed. |
25 weekly Hours of Being Together with an unknown Care Staff Member
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes from Baseline at 25 Sessions of Music Therapy in Negative Symptoms. Psychological Questionnaires
Time Frame: Up til 30 weeks
|
The Positive and Negative Syndrome Scale (PANSS).
Negative Subscale.
|
Up til 30 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Quality of Life from Baseline at 25 sessions. Psychological Questionnaire
Time Frame: Up till 30 weeks
|
Quality of Life (WHOQOL-Bref)
|
Up till 30 weeks
|
Functional Changes from Baseline to Termination. Psychological Questionnaire
Time Frame: Up to 30 weeks
|
Global Assessment of Functioning (GAF)
|
Up to 30 weeks
|
Changes of Anhedonic Features from Baseline at 25 Sessions of Music Therapy. Psychological Questionnaire
Time Frame: Up to 30 weeks
|
Brief negative Symptom Scale (BNSS).
Anhedonic Subscale.
|
Up to 30 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Inge N. Pedersen, Ass. Prof., Aalborg University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- N-20150054
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive SchizophreniaUnited Kingdom
-
University of Sao PauloUnknownRefractory Schizophrenia | Super Refractory SchizophreniaBrazil
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
University Hospital, BrestRecruitingSchizophrenia | Schizophrenia Prodromal | Schizophrenia, ChildhoodFrance
-
NYU Langone HealthNot yet recruitingTreatment-resistant SchizophreniaUnited States
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)RecruitingTreatment-resistant SchizophreniaUnited States
Clinical Trials on Music therapy
-
Case Comprehensive Cancer CenterCompletedMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin LymphomaUnited States
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedAutonomic Nervous System Imbalance | Hypothalamic Pituitary Adrenal Axis SuppressionUnited States
-
Icahn School of Medicine at Mount SinaiCompletedSARS-CoV 2 | Dyspnea | Post Covid-19 RespiratoryUnited States
-
Icahn School of Medicine at Mount SinaiCompleted
-
Children's Healthcare of AtlantaCompletedRespiratory Syncytial Virus InfectionsUnited States
-
University of MilanUnknownCritical Illness | Music Therapy | Hypnotics and SedativesItaly
-
Wayne State UniversityCompletedNeurological DisordersUnited States
-
Beth Israel Medical CenterCompleted
-
Yale UniversityCompletedPatient Satisfaction | Intravitreal Injections | Patient AnxietyUnited States
-
Milton S. Hershey Medical CenterRecruitingChronic Pain | AnxietyUnited States